Biotechnology-Europe Market Status and Trend Report 2013-2023
Report Summary
Biotechnology-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in Europe, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the Europe Biotechnology market as:
Europe Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
Europe Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
Europe Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biotechnology-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biotechnology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Biotechnology 2013-2017, and development forecast 2018-2023
Main market players of Biotechnology in Europe, with company and product introduction, position in the Biotechnology market
Market status and development trend of Biotechnology by types and applications
Cost and profit status of Biotechnology, and marketing status
Market growth drivers and challenges
The report segments the Europe Biotechnology market as:
Europe Biotechnology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Biotechnology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Sequencing
Nanobiotechnology
Tissue engineering and Regeneration
Fermentation
Cell Based Assay
PCR Technology
Chromatography Market
Others
Europe Biotechnology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
Europe Biotechnology Market: Players Segment Analysis (Company and Product introduction, Biotechnology Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Pfizer
Merck & Co.
Sanofi
AstraZeneca
Gilead
CELGENE CORPORATION
Biogen
Amgen, Inc
Abbott
Novo Nordisk A/S
Novartis AG
Lonza
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOTECHNOLOGY
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 Europe Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biotechnology in Europe 2013-2017
2.2 Consumption Market of Biotechnology in Europe by Regions
2.2.1 Consumption Volume of Biotechnology in Europe by Regions
2.2.2 Revenue of Biotechnology in Europe by Regions
2.3 Market Analysis of Biotechnology in Europe by Regions
2.3.1 Market Analysis of Biotechnology in Germany 2013-2017
2.3.2 Market Analysis of Biotechnology in United Kingdom 2013-2017
2.3.3 Market Analysis of Biotechnology in France 2013-2017
2.3.4 Market Analysis of Biotechnology in Italy 2013-2017
2.3.5 Market Analysis of Biotechnology in Spain 2013-2017
2.3.6 Market Analysis of Biotechnology in Benelux 2013-2017
2.3.7 Market Analysis of Biotechnology in Russia 2013-2017
2.4 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.1 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Biotechnology in Europe by Types
3.1.2 Revenue of Biotechnology in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Biotechnology in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biotechnology in Europe by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biotechnology by Downstream Industry in Germany
4.2.2 Demand Volume of Biotechnology by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Biotechnology by Downstream Industry in France
4.2.4 Demand Volume of Biotechnology by Downstream Industry in Italy
4.2.5 Demand Volume of Biotechnology by Downstream Industry in Spain
4.2.6 Demand Volume of Biotechnology by Downstream Industry in Benelux
4.2.7 Demand Volume of Biotechnology by Downstream Industry in Russia
4.3 Market Forecast of Biotechnology in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
5.1 Europe Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Biotechnology in Europe by Major Players
6.2 Revenue of Biotechnology in Europe by Major Players
6.3 Basic Information of Biotechnology by Major Players
6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson Services, Inc.
7.1.1 Company profile
7.1.2 Representative Biotechnology Product
7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company profile
7.2.2 Representative Biotechnology Product
7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biotechnology Product
7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Biotechnology Product
7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Biotechnology Product
7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Biotechnology Product
7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
7.7.1 Company profile
7.7.2 Representative Biotechnology Product
7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
7.8.1 Company profile
7.8.2 Representative Biotechnology Product
7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
7.9.1 Company profile
7.9.2 Representative Biotechnology Product
7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
7.10.1 Company profile
7.10.2 Representative Biotechnology Product
7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
7.11.1 Company profile
7.11.2 Representative Biotechnology Product
7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
7.12.1 Company profile
7.12.2 Representative Biotechnology Product
7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
7.13.1 Company profile
7.13.2 Representative Biotechnology Product
7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
7.14.1 Company profile
7.14.2 Representative Biotechnology Product
7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOTECHNOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biotechnology in This Report
1.2 Commercial Types of Biotechnology
1.2.1 DNA Sequencing
1.2.2 Nanobiotechnology
1.2.3 Tissue engineering and Regeneration
1.2.4 Fermentation
1.2.5 Cell Based Assay
1.2.6 PCR Technology
1.2.7 Chromatography Market
1.2.8 Others
1.3 Downstream Application of Biotechnology
1.3.1 Health
1.3.2 Food & Agriculture
1.3.3 Natural Resources & Environment
1.3.4 Industrial Processing
1.3.5 Bioinformatics
1.3.6 Others
1.4 Development History of Biotechnology
1.5 Market Status and Trend of Biotechnology 2013-2023
1.5.1 Europe Biotechnology Market Status and Trend 2013-2023
1.5.2 Regional Biotechnology Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biotechnology in Europe 2013-2017
2.2 Consumption Market of Biotechnology in Europe by Regions
2.2.1 Consumption Volume of Biotechnology in Europe by Regions
2.2.2 Revenue of Biotechnology in Europe by Regions
2.3 Market Analysis of Biotechnology in Europe by Regions
2.3.1 Market Analysis of Biotechnology in Germany 2013-2017
2.3.2 Market Analysis of Biotechnology in United Kingdom 2013-2017
2.3.3 Market Analysis of Biotechnology in France 2013-2017
2.3.4 Market Analysis of Biotechnology in Italy 2013-2017
2.3.5 Market Analysis of Biotechnology in Spain 2013-2017
2.3.6 Market Analysis of Biotechnology in Benelux 2013-2017
2.3.7 Market Analysis of Biotechnology in Russia 2013-2017
2.4 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.1 Market Development Forecast of Biotechnology in Europe 2018-2023
2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Biotechnology in Europe by Types
3.1.2 Revenue of Biotechnology in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Biotechnology in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biotechnology in Europe by Downstream Industry
4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biotechnology by Downstream Industry in Germany
4.2.2 Demand Volume of Biotechnology by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Biotechnology by Downstream Industry in France
4.2.4 Demand Volume of Biotechnology by Downstream Industry in Italy
4.2.5 Demand Volume of Biotechnology by Downstream Industry in Spain
4.2.6 Demand Volume of Biotechnology by Downstream Industry in Benelux
4.2.7 Demand Volume of Biotechnology by Downstream Industry in Russia
4.3 Market Forecast of Biotechnology in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOTECHNOLOGY
5.1 Europe Economy Situation and Trend Overview
5.2 Biotechnology Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOTECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Biotechnology in Europe by Major Players
6.2 Revenue of Biotechnology in Europe by Major Players
6.3 Basic Information of Biotechnology by Major Players
6.3.1 Headquarters Location and Established Time of Biotechnology Major Players
6.3.2 Employees and Revenue Level of Biotechnology Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOTECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson Services, Inc.
7.1.1 Company profile
7.1.2 Representative Biotechnology Product
7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc.
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company profile
7.2.2 Representative Biotechnology Product
7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biotechnology Product
7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Biotechnology Product
7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Biotechnology Product
7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi
7.6 AstraZeneca
7.6.1 Company profile
7.6.2 Representative Biotechnology Product
7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca
7.7 Gilead
7.7.1 Company profile
7.7.2 Representative Biotechnology Product
7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead
7.8 CELGENE CORPORATION
7.8.1 Company profile
7.8.2 Representative Biotechnology Product
7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION
7.9 Biogen
7.9.1 Company profile
7.9.2 Representative Biotechnology Product
7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen
7.10 Amgen, Inc
7.10.1 Company profile
7.10.2 Representative Biotechnology Product
7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.11 Abbott
7.11.1 Company profile
7.11.2 Representative Biotechnology Product
7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott
7.12 Novo Nordisk A/S
7.12.1 Company profile
7.12.2 Representative Biotechnology Product
7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S
7.13 Novartis AG
7.13.1 Company profile
7.13.2 Representative Biotechnology Product
7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG
7.14 Lonza
7.14.1 Company profile
7.14.2 Representative Biotechnology Product
7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOTECHNOLOGY
8.1 Industry Chain of Biotechnology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOTECHNOLOGY
9.1 Cost Structure Analysis of Biotechnology
9.2 Raw Materials Cost Analysis of Biotechnology
9.3 Labor Cost Analysis of Biotechnology
9.4 Manufacturing Expenses Analysis of Biotechnology
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOTECHNOLOGY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
